A critical advance in cancer investigation is arising with the use of VHH fragments to reactivate damaged p53. This essential malignant protector protein is frequently disabled in many kinds of tumors, leading https://social-galaxy.com/story7521617/nanobodies-revive-tumor-suppressor-p53-a-promising-pathway-for-malignant-therapy